Highlights

• Functions as neuroprotection, neuropathy, as well as neuron repair and regeneration

• Clean and safe raw materials; advanced purity technology

• The most similar structure between mNGF and human NGF, no species specificity

• Complete clinical trials: non-clinical part, clinical Phase I, II, III, IV

• mNGF has been listed in Chinese Pharmacopoeia (2015 Edition)

•  More than 13 million doses are being used in China in 2015

Dosage Form 

Freeze-dried loose powder for injection

Specification

30μg mNGF/vial, biological activity ≥15000AU